SETIAWAN, S. I.; ASCOBAT, P. ADVERSE REACTIONS TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS AS A RISK FACTOR OF PULMONARY TUBERCULOSIS TREATMENT DEFAULT IN JAKARTA, INDONESIA. Int J App Pharm 2019, 11, 80-83.